Biocartis Group N.V.
BIOGF · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Revenue | $57 | $48 | $43 | $37 |
| % Growth | 19.1% | 11.9% | 15.2% | – |
| Cost of Goods Sold | $30 | $34 | $26 | $21 |
| Gross Profit | $28 | $14 | $17 | $16 |
| % Margin | 48.2% | 29.7% | 39.1% | 43% |
| R&D Expenses | $38 | $48 | $41 | $40 |
| G&A Expenses | $4 | $3 | $3 | $5 |
| SG&A Expenses | $9 | $6 | $7 | $10 |
| Sales & Mktg Exp. | $5 | $3 | $3 | $5 |
| Other Operating Expenses | $27 | $0 | $0 | $0 |
| Operating Expenses | $74 | $77 | $63 | $71 |
| Operating Income | -$47 | -$63 | -$47 | -$56 |
| % Margin | -81.8% | -129.8% | -108.7% | -148.5% |
| Other Income/Exp. Net | -$19 | -$9 | -$16 | -$9 |
| Pre-Tax Income | -$66 | -$72 | -$63 | -$64 |
| Tax Expense | -$0 | -$0 | -$0 | -$0 |
| Net Income | -$65 | -$71 | -$63 | -$64 |
| % Margin | -113.7% | -148.1% | -145.9% | -171.1% |
| EPS | -1.08 | -1.24 | -1.11 | -1.14 |
| % Growth | 12.9% | -11.7% | 2.6% | – |
| EPS Diluted | -1.08 | -1.24 | -1.11 | -1.14 |
| Weighted Avg Shares Out | 61 | 58 | 57 | 56 |
| Weighted Avg Shares Out Dil | 61 | 58 | 57 | 56 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $1 | $0 | $0 |
| Interest Expense | $11 | $9 | $10 | $7 |
| Depreciation & Amortization | $10 | $10 | $10 | $10 |
| EBITDA | -$44 | -$53 | -$43 | -$47 |
| % Margin | -76.5% | -108.9% | -100.2% | -126.5% |